Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
1 other identifier
interventional
170
1 country
1
Brief Summary
The aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2020
CompletedStudy Start
First participant enrolled
February 15, 2020
CompletedFirst Posted
Study publicly available on registry
February 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2025
CompletedApril 30, 2026
April 1, 2026
3.7 years
February 15, 2020
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
In-Hospital growth in extremely preterm infants
Compare the in-hospital growth in extremely preterm infants between routine fortification vs selective fortifications groups
Remaining length of NICU admission from the time of randomization (approximately 2 years from recruitment starts)
Necrotizing Enterocolitis (NEC)
Compare the difference in the incidence of NEC among the two groups
Remaining length of NICU admission from the time of randomization (approximately 2 years from recruitment starts)
Neurodevelopmental outcome
Assess the difference (if any) in developmental outcome at two years between the two group using Bayley IV
Assessment will happen at two years adjusted age ( approximately 4 years from the time recruitment starts)
Secondary Outcomes (1)
The difference in growth (if any) at two years
Assessment will be completed at two years adjusted age ( approximately 4 years from the time recruitment starts)
Study Arms (2)
Early Routine Fortification
EXPERIMENTALHuman Milk Donor Fortifier added to preterm human milk (maternal or donor) when feeds of 150 ml/kg/day are reached (120Kcal/kg/day)
Selective Fortification
ACTIVE COMPARATORHuman Milk Donor Fortifier added to preterm human milk (maternal or donor) only for weight gain less than 15g/kg/day after full feeds of 180 ml/kg/day are achieved (120 Kcal/kg/day). If milk of any infant in the selective fortification group gets fortified the volume will be decreased to 150 ml/kg/day to keep the total caloric intake equal.
Interventions
Infants will be randomized to two groups. Both groups will be fed Premature Human Milk (either Maternal own milk or Premature donor human milk). However, one group will get fortified with Donor Human Milk Fortifier once full feed is reached while the second group will get fortified using the same fortifier only when weight gain is suboptimal.
Eligibility Criteria
You may qualify if:
- All extremely preterm infants with gestational age less or equal to 27 weeks who are admitted to the NICU prior to day of life seven and the first enteral feeding
You may not qualify if:
- Infants with severe congenital anomalies such as chromosomal trisomy, congenital heart disease, and abdominal wall defect
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Crouse Hospitallead
Study Sites (1)
Crouse Hospital
Syracuse, New York, 13210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bouraa Bou Aram, MD
Crouse Hospital
- PRINCIPAL INVESTIGATOR
Swati Murthy, MD
Crouse Hospital
- PRINCIPAL INVESTIGATOR
Steven J Gross, MD
Crouse Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Attending Physician, Neonatologist
Study Record Dates
First Submitted
February 15, 2020
First Posted
February 25, 2020
Study Start
February 15, 2020
Primary Completion
October 31, 2023
Study Completion
November 11, 2025
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share